White Paper

A Review Of The Changing Trends And Use Of eCOA In Clinical Trials

GettyImages-1424259620 ecoa

The digital transformation of electronic clinical outcome assessments (eCOAs) is being propelled by factors such as the advent of new technology, the maturation of digital organizations, and increased endorsement from regulatory bodies. Sponsors can capitalize on the advantages offered by flexible and integrated eCOA tools, resulting in expedited study start-up times, improved data quality, enhanced study management efficiencies, superior patient-reporting experiences, and cost savings.

This white paper delves into the industry and regulatory trends converging to drive the broader adoption of eCOA in clinical trials. The latter section of the document presents an overview of Medidata's Rave eCOA, a user-friendly and adaptable solution equipped with a global library of preconfigured and preapproved eCOA questionnaires. Operating on the Medidata Rave Clinical Cloud's unified data platform, it establishes a singular source of truth for all study-related data, facilitating accurate capture of patient outcomes data. These features collectively empower sponsors to utilize Rave eCOA to elevate the patient-reporting experience, fostering trials that prioritize patients while alleviating the burden on sites and clinical teams.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of ECM Connection? Subscribe today.

Subscribe to ECM Connection X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to ECM Connection

Medidata, a Dassault Systemes company